Blockchain Registration Transaction Record

CD BioSciences Launches One-Stop Anti-Aging Drug Development Service

CD BioSciences launches a complete one-stop anti-aging drug development service for pharma and research, covering discovery, preclinical models, and safety testing.

This development significantly lowers barriers to entry in the rapidly growing longevity sector, potentially accelerating the timeline for bringing effective anti-aging therapies to market. For researchers and pharmaceutical companies, it provides access to specialized expertise and a comprehensive suite of tools—from target discovery to preclinical models—that would be costly and time-consuming to develop in-house. For the general public, it represents a step forward in translating scientific understanding of aging into tangible medical interventions, which could one day lead to treatments that extend healthspan and combat age-related diseases like Alzheimer's and cardiovascular conditions. By streamlining R&D, this service could foster more innovation and collaboration in a field poised to redefine healthcare and human longevity.